» Articles » PMID: 6794

Evaluation of the Discriminative Effects of Morphine in the Rat

Overview
Specialty Pharmacology
Date 1976 Jul 1
PMID 6794
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The discriminative effects produced by morphine in the rat were evaluated using a two-choice, discrete trial avoidance task. Stimulus control of behavior was attained with a dose of morphine one-third to one-tenth of that used in previous studies. Morphine produced dose-related discriminative effects over a 100-fold dose range. The stimulus control produced by the discriminative effects of morphine met the following criteria for classification as a specific narcotic effect: 1) oxymorphone, levorphanol, methadone and meperidine, narcotic analgesics from diverse chemical families, also produced dose-related morphine-like discriminative effects; 2) dextrorphan and thebaine, compounds structurally related to the narcotics but lacking narcotic activity, failed to produce morphine-like discriminative effects; 3) effects were blocked by the narcotic antagonist naloxone; and 4) tolerance to the discriminative effects developed upon the repeated administration of morphine and cross-tolerance extended to methadone. The discriminative effects produced by morphine were further characterized by evaluating the capacity of prototypes of other classes of psychoactive drugs to produce morphine-like discriminative effects. Profadol and pentazocine, euphorogenic analgesics with mixed agonist and narcotic antagonist properties, produced dose-related morphine-like discriminative effects whereas cyclazocine, a dysphorogenic analgesic with mixed agonist and narcotic-antagonist properties, did not. In addition, the nonopioid psychoactive drugs d-amphetamine, pentobarbital and chlorpromazine also failed to produce morphine-like discriminative effects. Thus, morphine-like discriminative effects were produced uniquely by the narcotic analgesics and euophorogenic analgesics with mixed agonist and narcotic antagonist properties. These results suggest that the component of action of morphine that enables it to function as a discriminative stimulus in the rat is analogous to the component of action of morphine responsible for producing subjective effects in man.

Citing Articles

The effects of chronic neuropathic pain states on the discriminative stimulus effect of fentanyl and other MOR agonists.

Burgess G, Traynor J, Jutkiewicz E bioRxiv. 2024; .

PMID: 39605679 PMC: 11601629. DOI: 10.1101/2024.11.19.624329.


Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?.

Townsend E, Banks M CNS Drugs. 2020; 34(5):449-461.

PMID: 32248427 PMC: 7223115. DOI: 10.1007/s40263-020-00722-8.


Drug Discrimination: Historical Origins, Important Concepts, and Principles.

Porter J, Prus A, Overton D Curr Top Behav Neurosci. 2018; 39:3-26.

PMID: 29637526 DOI: 10.1007/7854_2018_40.


Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents.

Altarifi A, David B, Muchhala K, Blough B, Akbarali H, Negus S J Psychopharmacol. 2017; 31(6):730-739.

PMID: 28142305 PMC: 5646680. DOI: 10.1177/0269881116689257.


Drug Discrimination and the Analysis of Private Events.

Kangas B, Maguire D Behav Anal (Wash D C). 2016; 16(4):159-168.

PMID: 27928551 PMC: 5137942. DOI: 10.1037/bar0000032.